Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19

SN Comprehensive Clinical Medicine(2022)10.1007/s42399-022-01121-4Source: DataRank Database

Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19 is a research paper published in SN Comprehensive Clinical Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: hybridTopics (9)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jeanne Gosselin,Bonita Libman,Benjamin Littenberg ORCID,Ralph C. Budd ORCID,Brendan L. Thoms ORCID

Live enrichment

PubMed:35079694

Foundation for the National Institutes of Health

Grant: GM118228

National Institutes of Health

Grant: 3P30GM118228-05S1

Vermont Immunology/Infectious Diseases Center

NIGMS NIH HHS

Grant: P30 GM118228

hybridLicense: cc-by

publisherhttps://link.springer.com/content/pdf/10.1007/s42399-022-01121-4.pdf

publisherhttps://link.springer.com/article/10.1007/s42399-022-01121-4/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8776555

https://doi.org/10.1007/s42399-022-01121-4

https://doi.org/10.21203/rs.3.rs-835734/v1

Fields of Study

0303 health sciences03 medical and health sciences

Keywords

Original PaperArticleBaricitinibCoronavirus disease-19 (COVID-19)Critical careCytokine stormJAK inhibitor

Sustainable Development Goals

SDG 3: 3. Good health